MustGrow Biologics Corp (MGROF)

Reports 2Q22 Operating Results


Joe GomesMedia Inquiries
Senior Generalist Equity Analyst
August 29, 2022
Report ID: 25174
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

Ticker
MGROF
Current Price
$0.8898
Market Cap
$44.6M
Price Target
Refer to Report
52wk Range
$0.5694 - $2.14
Related Research Reports
2/7/2024

Reaching Another State
Reaching Another State (MGROF)
12/12/2023

New Commercial Agreement with Bayer
New Commercial Agreement with Bayer (MGROF)
11/16/2023

Knocking Down the First Domino
Knocking Down the First Domino (MGROF)
11/8/2023

Receiving More Approval
Receiving More Approval (MGROF)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.